Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
contrast agent |
| gptkbp:activeIngredient |
gptkb:iopromide
|
| gptkbp:administeredBy |
intravenous injection
|
| gptkbp:approvedBy |
1985
|
| gptkbp:ATCCode |
gptkb:V08AB05
|
| gptkbp:chemicalFormula |
gptkb:C18H24I3N3O8
|
| gptkbp:contraindication |
hypersensitivity to iopromide
|
| gptkbp:FDAApproved |
yes
|
| https://www.w3.org/2000/01/rdf-schema#label |
Ultravist
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Bayer
|
| gptkbp:marketedIn |
gptkb:Europe
gptkb:United_States |
| gptkbp:molecularWeight |
791.12 g/mol
|
| gptkbp:osmolarity |
low-osmolar
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:sideEffect |
nausea
vomiting injection site pain allergic reactions |
| gptkbp:usedFor |
medical imaging
|
| gptkbp:usedIn |
gptkb:computed_tomography
angiography urography |
| gptkbp:bfsParent |
gptkb:Bayer_HealthCare
|
| gptkbp:bfsLayer |
6
|